Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
eli lilly
7
×
ipo
7
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
fda
indiana blog main
indiana top stories
startups
deals
glaxosmithkline
allergan
clinical trials
crispr
genentech
medical devices
novartis
What
bio
roundup
drugs
pharmaceutical
black
companies
diamond’s
life
moves
raise
science
typically
week
advance
alzheimer’s
appetite
august
bails
big
biology
biotech
bosley's
bosley’s
brand
bread
bridge
bridgebio
bucks
busy
butter
buyout
cancer
capital
car
cas
cash
ceo
company
continue
crime
Language
unset
Current search:
ipo
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs